There has been no news about medical device firm SI-BONE Inc (NASDAQ:SIBN) for more than two months but over the course of the past month the company’s stock has been on the radars of many investors.
During the period, the stock has managed to clock gains of as much as 9% and it might be the right time for investors to consider taking a closer look at the company. Back on July 14 this year, the company, which is involved in helping with muscoskeletal disorders, announced that a positive coverage policy had been established by Centene Corporation for minimally invasive SI joint fusion.
It was a significant announcement since Centene is regarded as one of the most influential intermediaries when it comes to the connection between government backed and privately insured health care initiatives.
At this point in time, Centene boasts of as many as 25 million members in the United States alone and such an announcement is also an important one for SI-BONE, since the company could also get involved in this space. However, at the same time, it is important for investors to keep an eye out for any fresh news about the company.
